Vascular and cardiac functional and structural screening to identify risk of future morbid events: preliminary observations.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of the American Society of Hypertension : JASH

• Publication date

  2011-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jash.2011.05.001PMID 21719371
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Systematic Review and Meta-analysis

  2010cited by this paper
• Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.

  2009cited by this paper
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• Risk prediction of coronary heart disease based on retinal vascular caliber (from the Atherosclerosis Risk In Communities [ARIC] Study).

  2008cited by this paper
• Defining a rational approach to screening for cardiovascular risk in asymptomatic patients.

  2008cited by this paper
• Time to foster a rational approach to preventing cardiovascular morbid events.

  2008cited by this paper
• General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study

  2008cited by this paper
• Identifying Early Cardiovascular Disease to Target Candidates for Treatment

  2008cited by this paper
• Framingham-based tools to calculate the global risk of coronary heart disease

  2007cited by this paper
• Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.

  2007cited by this paper
• 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

  2007cited by this paper
• Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis

  2007cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

  2007cited by this paper
• Beneficial effects of valsartan in asymptomatic individuals with vascular or cardiac abnormalities: the DETECTIV Pilot Study.

  2007cited by this paper
• Arterial stiffness as a risk factor for coronary atherosclerosis

  2007cited by this paper
• Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options.

  2005cited by this paper
• The prognostic value of N-terminal proB-type natriuretic peptide

  2005cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

  2005cited by this paper
• New insights into the significance of microalbuminuria

  2004cited by this paper
• Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study).

  2004cited by this paper
• Framingham risk score and prediction of lifetime risk for coronary heart disease.

  2004cited by this paper
• Screening for early detection of cardiovascular disease in asymptomatic individuals.

  2003cited by this paper
• Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

  2003cited by this paper
• Framingham-based tools to calculate the global risk of coronary heart disease

  2003cited by this paper
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

  2003cited by this paper
• AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology.

  2001cited by this paper
• AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology.

  2001cited by this paper
• Cardiovascular protection and blood pressure reduction: a meta-analysis.

  2001cited by this paper
• The Blood Pressure Lowering Treatment Trialists' Collaboration

  2001cited by this paper
• Exercise blood pressure predicts cardiovascular mortality in middle-aged men.

  1994cited by this paper

• Protocol for the WARM Hearts study: examining cardiovascular disease risk in middle-aged and older women - a prospective, observational cohort study

  2021cites this paper
• Self-compassion and responses to health information in middle-aged and older women: An observational cohort study

  2020cites this paper
• Acute Effect of High-Intensity Interval Versus Moderate-Intensity Continuous Exercise on Blood Pressure and Arterial Compliance in Middle-Aged and Older Hypertensive Women With Increased Arterial Stiffness.

  2020cites this paper
• Early cardiovascular structural and functional abnormalities as a guide to future morbid events.

  2020cites this paper
• Frailty status and cardiovascular disease risk profile in middle-aged and older females.

  2020cites this paper
• Immediate post-exercise blood pressure and arterial compliance in middle-aged and older normotensive females: A cross-sectional study

  2020cites this paper
• Three Finite Vascular Responses that Cause Coronary Heart Disease and Cardiovascular Disease: Implications for Diagnosis and Treatment

  2019cites this paper
• Monitoring Cardiovascular Disease Progression

  2019cites this paper
• Cardiovascular Disease Progression: A Target for Therapy?

  2018cites this paper
• The role of noninvasive cardiovascular testing, applied clinical nutrition and nutritional supplements in the prevention and treatment of coronary heart disease

  2018cites this paper
• Exploring the relationship between self-efficacy, physical activity, and cardiovascular disease risk in women at moderate to high risk for cardiovascular disease

  2018influential citation
• Effect of nebivolol or atenolol vs. placebo on cardiovascular health in subjects with borderline blood pressure: the EVIDENCE study

  2017cites this paper
• Protocol for the HAPPY Hearts study: cardiovascular screening for the early detection of future adverse cardiovascular outcomes in middle-aged and older women: a prospective, observational cohort study

  2017influential citation
• Office Blood Pressure and Cardiovascular Disease: Pathophysiologic Implications for Diagnosis and Treatment.

  2017cites this paper
• Slowing the Progression of Cardiovascular Disease.

  2016cites this paper
• Prediction models for cardiovascular disease risk in the general population: systematic review

  2016cites this paper
• Prevention of cardiovascular disease.

  2015cites this paper
• Utility of Framingham risk score in urban emergency department patients with asymptomatic hypertension.

  2014cites this paper
• Identifying the risk and preventing the consequences of cardiovascular disease.

  2013cites this paper
• The message is clear: prevent as well as treat acute myocardial infarction.

  2013cites this paper
• Prehypertension and the cardiometabolic syndrome: pathological and clinical consequences

  2013cites this paper
• Dendritic cells in cardiovascular diseases: epiphenomenon, contributor, or therapeutic opportunity.

  2013cites this paper
• Preventing heart failure: a critique of strategies.

  2013cites this paper
• Effect of carvedilol, lisinopril and their combination on vascular and cardiac health in patients with borderline blood pressure: the DETECT Study

  2013cites this paper
• The Problem With Cardiovascular Disease Prevention Guidelines

  2012cites this paper
• Chronic Heart Failure: We Are Fighting the Battle, but Are We Winning the War?

  2012cites this paper
• Underuse of cardiovascular preventive pharmacotherapy in patients presenting with ST-elevation myocardial infarction.

  2012cites this paper
• Disease Prevention in Heart Failure

  2011cites this paper